Earnings Call to be Conducted Tuesday, November 6 at 8:00 am EST HAWTHORNE, N.Y. --(BUSINESS WIRE)--Oct. 29, 2018-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2018 , on Monday,
License agreement for anti-fungal peptide treatment, Novexatin® HAWTHORNE, N.Y. --(BUSINESS WIRE)--Sep. 28, 2018-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) announced today that it has terminated the license agreement with NovaBiotics for the onychomycosis drug,
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Aug. 9, 2018-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 2018 . Quarter ended June 30, 2018 Highlights - compared to June 30, 2017 Net sales of $154.6 million
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Aug. 2, 2018-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2018 , after the close of market on Thursday, August 9, 2018 .
For Fiscal Year Ended March 31, 2018 HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jun. 22, 2018-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO, “Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2018 , filed with the Securities and Exchange Commission (the “SEC”), is
HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 17, 2018-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2018 . Quarter ended March 31, 2018 Highlights ─ compared to March 31, 2017 Net sales of
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Feb. 7, 2018-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and nine months ended December 31, 2017 . Quarter ended December 31, 2017 Highlights ─ compared to December 31, 2016
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jan. 31, 2018-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2017 , after the close of market on Wednesday, February 7, 2018 .
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Nov. 7, 2017-- November 7, 2017 -- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and six months ended September 30, 2017 . Quarter ended September 30, 2017 Highlights - compared
Earnings Call to Discuss Results to be Conducted Wednesday, November 8 at 8:00 am ET HAWTHORNE, N.Y. --(BUSINESS WIRE)--Oct. 30, 2017-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("TARO" or the "Company") announced today that it plans to release its financial results for the quarter and six
Alerts are e-mailed to you whenever certain new company information is posted to this site.
